Central Data Catalog


1 Bejon, P., J. Cook, E. Bergmann-Leitner, A. Olotu, J. Lusingu, J. Mwacharo, J. Vekemans, P. Njuguna, A. Leach, M. Lievens, S. Dutta, L. von Seidlein, B. Savarese, T. Villafana, M. M. Lemnge, J. Cohen, K. Marsh, P. H. Corran, E. Angov, E. M. Riley, and C. J. Drakeley. "Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children." (2011).
2 Bejon, P., S. Keating, J. Mwacharo, O. K. Kai, S. Dunachie, M. Walther, T. Berthoud, T. Lang, J. Epstein, D. Carucci, P. Moris, J. Cohen, S. C. Gilbert, N. Peshu, K. Marsh, and A. V. Hill. "Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naive and malaria-exposed individuals." (2006).
3 Enosse, Sonia, Carlota Dobaño, Diana Quelhas, John J Aponte, Marc Lievens, Amanda Leach, Jahit Sacarlal, Brian Greenwood, Jessica Milman, Filip Dubovsky, Joe Cohen, Ricardo Thompson, W Ripley Ballou, Pedro L Alonso, David J Conway, and Colin J Sutherland. "RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection." PLoS Clin Trials 1, no. 1 (2006).
4 Guinovart, Caterina, John J Aponte, Jahit Sacarlal, Pedro Aide, Amanda Leach, Quique Bassat, Eusébio Macete, Carlota Dobaño, Marc Lievens, Christian Loucq, W Ripley Ballou, Joe Cohen, and Pedro L Alonso. "Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children." PLoS ONE 4, no. 4 (2009).
5 Macete, E, J J Aponte, C Guinovart, J Sacarlal, O Ofori-Anyinam, I Mandomando, M Espasa, C Bevilacqua, A Leach, M C Dubois, D G Heppner, L Tello, J Milman, J Cohen, F Dubovsky, N Tornieporth, R Thompson, and P L Alonso. "Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1-4 in Mozambique." Trop. Med. Int. Health 12, no. 1 (2007): 37-46.
6 Nigatu, W., D. J. Nokes, F. Enquselassie, D. W. Brown, B. J. Cohen, A. J. Vyse, and F. T. Cutts. "Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA)." J. Virol. Methods (1999).
7 Nokes, D. J., F. Enquselassie, W. Nigatu, A. J. Vyse, B. J. Cohen, D. W. Brown, and F. T. Cutts. "Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia." Bull. World Health Organ. (2001).
8 Pretorius, Marthi A., Shabir A. Madhi, Cheryl Cohen, Dhamari Naidoo, Michelle Groome, Jocelyn Moyes, Amelia Buys, Sibongile Walaza, Halima Dawood, Meera Chhagan, Sumayya Haffjee, Kathleen Kahn, Adrian Puren, and Marietjie Venter. "Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness--South Africa, 2009-2010." J. Infect. Dis. (2012).
9 Sartorius, Benn, C. Cohen, T. Chirwa, G. Ntshoe, A. Puren, and K. Hofman. "Identifying high-risk areas for sporadic measles outbreaks: lessons from South Africa." Bull. World Health Organ. (2013).